NTN Buzztime, Inc. (NTN): Price and Financial Metrics
GET POWR RATINGS... FREE!
NTN Stock Price Chart Interactive Chart >
NTN Price/Volume Stats
|Current price||$5.40||52-week high||$7.76|
|Prev. close||$2.67||52-week low||$0.94|
|Day high||$5.48||Avg. volume||1,629,816|
|50-day MA||$3.91||Dividend yield||N/A|
|200-day MA||$2.51||Market Cap||16.08M|
NTN Buzztime, Inc. (NTN) Company Bio
NTN Buzztime Inc. develops and distributes interactive entertainment. The Company owns and operates interactive consumer marketing television networks that broadcast a variety of interactive games, advertisements, and information programming. NTN distributes its programs to restaurants, sports bars, hotels, clubs, and military bases in North America.
Most Popular Stories View All
NTN Latest News Stream
|Loading, please wait...|
NTN Latest Social Stream
View Full NTN Social Stream
Latest NTN News From Around the Web
Below are the latest news stories about Ntn Buzztime Inc that investors may wish to consider to help them evaluate NTN as an investment opportunity.
NTN Buzztime, Inc. (NYSE American: NTN) today announced that it plans to effect a one for two reverse stock split of its outstanding shares of common stock immediately prior to the closing of the merger with Brooklyn ImmunoTherapeutics LLC, which is anticipated to occur on March 25, 2021. The shares of common stock of the resulting company is expected to commence trading on March 26, 2021 on the NYSE American under the trading symbol "BTX".
NTN Buzztime (NTN) soars 62% after-hours after its stockholders approved the proposed merger between NTN and Brooklyn ImmunoTherapeutics.The merger is expected to close in the next two weeks. At the special meeting, following proposals were approved:Issuance of NTN common shares to the members of Brooklyn,Authorizing an amendment to effect a reverse stock...
NTN Buzztime Announces Approval of Merger with Brooklyn ImmunoTherapeutics by Stockholders at Special Meeting
NTN Buzztime, Inc. (NYSE American: NTN) today announced that its stockholders have approved the proposed merger between NTN and Brooklyn ImmunoTherapeutics LLC. The proposed merger remains subject to further customary closing conditions and regulatory approvals. NTN expects that the merger will close in the next two weeks.
Independent Advisory Firm ISS Recommends NTN Stockholders Vote FOR Proposed Merger and Asset Sale and ALL Related Proposals
CARLSBAD, Calif., March 8, 2021 /PRNewswire/ -- NTN Buzztime, Inc. (NYSE American: NTN) today announced that leading independent proxy advisory firm Institutional Shareholder Services, Inc. ("ISS") recommends that NTN stockholders vote "FOR" ALL PROPOSALS to be considered and voted on at…
NTN Buzztime Board of Directors Urges Stockholders to Vote FOR Proposed Merger and Asset Sale and ALL Related Proposals
CARLSBAD, Calif., March 1, 2021 /PRNewswire/ -- The board of directors of NTN Buzztime, Inc. (NYSE American: NTN) unanimously urges NTN's stockholders to vote FOR ALL the proposals to be voted on at the March 15, 2021 special meeting of stockholders, all of which relate to the proposed…
NTN Price Returns